News
Jiangsu Hengrui Pharmaceuticals Co Ltd, a global pharmaceutical company focusing on scientific and technological innovation, announced on March 25 that it has entered into an exclusive license ...
NEW YORK, NY / ACCESS Newswire / April 8, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn about a potential recovery under the federal securities ...
Concor’s investment in education is opening doors for young people to pursue meaningful careers and break the cycle of poverty By supporting The Tomorrow Trust, Concor is playing an active role ...
Concor continues to demonstrate that building infrastructure goes hand in hand with building brighter futures. As part of its longstanding commitment to corporate social responsibility, Concor’s ...
--logo-padding "" Sets the padding left and right of the logo --logo-padding-left 0 Sets the padding to the left of the logo --logo-padding-right 4 Sets the padding to the right of the logo Command ...
It’s not HBO, it’s Max — but the new standalone logo for Warner Bros. Discovery‘s streamer now certainly looks like HBO’s at a glance. The Max streaming service has quietly launched a ...
And, last month, the mRNA specialist announced that it had tapped Amy Mahery, an alum of Roivant Sciences and Merck KGaA’s EMD Serono, to serve as chief marketing officer. Meanwhile, Moderna has ...
Merck will partner with Chinese biotech Abbisko Therapeutics to market and sell the bone-tumor treatment pimicotinib globally, expanding its commercialization rights for the drug beyond Asia. The ...
Merck’s new formulation of the mega-blockbuster Keytruda, made in collaboration with Alteogen, could help to keep the drug’s patent cliff at bay. In a push to keep the Keytruda gravy train on the ...
Under the agreement, Hengrui Pharma has granted Merck exclusive rights to develop, manufacture, and commercialize HRS-5346 worldwide, excluding the Greater China region. Hengrui Pharma will ...
Lady Gaga was hit with a $100 million lawsuit by a California surf company over claims the pop star stole their logo for her new merchandise, according to documents obtained by FOX Business.
Merck & Co.’s subcutaneous (SC) formulation of Keytruda has matched up to the original intravenous (IV) version on two blood concentration measurements, paving way for a potential FDA approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results